Top

World Journal of Surgery

Published in:

01-11-2009

Prognostic Significance of the Metastatic Lymph Node Ratio in Gastric Cancer Patients

Authors: Naoto Fukuda, Yasuyuki Sugiyama, Akira Midorikawa, Hiroyuki Mushiake

Published in: World Journal of Surgery | Issue 11/2009

Abstract

Background

Lymph node metastasis is considered one of the most important prognostic factors in gastric cancer. However, the optimal system for accurate staging of lymph node metastasis for patients with gastric cancer remains controversial. This study was designed to investigate the prognostic significance of the metastatic lymph node ratio (MLR), which is calculated by dividing the number of metastatic lymph nodes by the total number of nodes harvested from patients with gastric cancer.

Methods

We retrospectively analyzed the clinical data of 186 consecutive patients diagnosed with gastric cancer who underwent curative gastrectomy at our hospital. The lymph node status was classified according to three systems: the International Union Against Cancer/American Joint Committee on Cancer (UICC/AJCC) system; the Japanese Gastric Cancer Association (JGCA) system; and an MLR-based system (MLR0: 0, MLR1: 0.01–0.19, MLR2: ≥0.2). The influence of the MLR on patient survival was determined using univariate Kaplan-Meier survival analysis, the generalized Wilcoxon test, and analysis with the multivariate Cox proportional hazards model.

Results

The 5-year survival rate of the patients with MLR0, MLR1, and MLR2 was 88.6%, 59.4%, and 13.4%, respectively. In addition to the MLR, the UICC/AJCC N category, JGCA n category, tumor stage (pT category), and tumor diameter significantly influenced the 5-year survival rate, as determined by univariate analysis. Multivariate analyses revealed that of the three factors used to stage lymph node involvement, MLR was the most significant prognostic factor.

Conclusions

The MLR is an important and easy-to-assess prognostic factor that should be considered for staging lymph node metastasis in patients with gastric cancer.

Adachi Y, Kamakura T, Mori M et al (1994) Prognostic significance of the number of positive lymph nodes in gastric carcinoma. Br J Surg 81:414–416PubMedCrossRef

Yokota T, Ishiyama S, Saito T et al (2004) Lymph node metastasis as a significant prognostic factor in gastric cancer: a multi logistic regression analysis. Scand J Gastroenterol 39:380–384PubMedCrossRef

Wu ZY, Li JH, Abe S et al (2007) Effect of lymph node micrometastases on prognosis of gastric carcinoma. World J Gastroenterol 13:4122–4125PubMed

Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma, 2nd English edition. Gastric Cancer 1:10–24PubMedCrossRef

Sobin LH, Fleming ID (1997) TNM classification of malignant tumors, Fifth edition Union Internationale Contre le Cancer and American Joint Committee on Cancer. Cancer 80:1803–1804PubMedCrossRef

Nitti D, Marchet A, Olivieri M et al (2003) Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 10:1077–1085PubMedCrossRef

Bando E, Yoneyama Y, Taniguchi K et al (2002) Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 9:775–784PubMedCrossRef

Inoue K, Nakane Y, Iiyama H et al (2002) The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 9:27–34PubMedCrossRef

Ozgüc H, Sönmer Y, Yerci O (2008) Metastatic/resected lymph nodes ratio-based classification in gastric cancer. Turk J Gastroenterol 19:2–7PubMed

10.

Saito H, Fukumoto Y, Osaki T et al (2008) Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol 97:132–135PubMedCrossRef

11.

Persiani R, Rausei S, Biondi A et al (2008) Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer. Euro J Surg Oncol 34:519–524

12.

Huang CM, Lin BJ, Lu HS et al (2008) Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardia and fundus. World J Gastroenterol 14:4383–4388PubMedCrossRef

13.

Yamaguchi T (2003) JGCA gastric cancer treatment guideline: a new trend in gastric cancer treatment. Jpn Medical Association J 46:238–245

14.

Ichikura T, Tomimatsu S, Uefuji K et al (1999) Evaluation of the New American Joint Committee on Cancer/International Union against cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification. Cancer 86:553–558PubMedCrossRef

15.

Fujii K, Isozaki H, Okajima K et al (1999) Clinical evaluation of lymph node metastasis in gastric cancer defined by the fifth edition of the TNM classification in comparison with the Japanese system. Br J Surg 86:685–689PubMedCrossRef

16.

Hemaneck P (2000) The superiority of the new International Union Against Cancer and American Joint Committee on Cancer TNM staging of gastric carcinoma. Cancer 88:1763–1765CrossRef

17.

Hundahl SA, Phillips JL, Menck HR (2000) National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer 88:921–932PubMedCrossRef

18.

Okusa T, Nakane Y, Boku T et al (1990) Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg Gynecol Obstet 170:488–494PubMed

19.

Siewert JR, Bottcher FK, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228:449–461PubMedCrossRef

20.

Yu W, Choi GS, Whang J et al (1997) Comparison of five systems for staging lymph node metastasis in gastric cancer. Br J Surg 84:1305–1309PubMedCrossRef

21.

Wagner PK, Ramaswamy A, Schmitz-Moormann P et al (1991) Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 78:825–827PubMedCrossRef

22.

Kodera Y, Yamamura Y, Shimizu Y et al (1998) Lymph node status assessment for gastric carcinoma: is the number of metastatic lymph nodes really practical as a parameter for N categories in the TNM classification? J Surg Oncol 69:15–20PubMedCrossRef

Title: Prognostic Significance of the Metastatic Lymph Node Ratio in Gastric Cancer Patients
Authors: Naoto Fukuda
Yasuyuki Sugiyama
Akira Midorikawa
Hiroyuki Mushiake
Publication date: 01-11-2009
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 11/2009
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-009-0205-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Prognostic Significance of the Metastatic Lymph Node Ratio in Gastric Cancer Patients

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2009

Molecular Genetics of Parathyroid Disease

Prospective Study of Intra-Abdominal Pressure Following Major Elective Abdominal Surgery

Minimally Invasive Parathyroidectomy: Benefits and Requirements of Localization, Diagnosis, and Intraoperative PTH Monitoring. Long-Term Results

Patients with Less Than Three Episodes of Diverticulitis May Benefit from Elective Laparoscopic Sigmoidectomy

Comparison of Invasiveness Between Laparoscopy-Assisted Total Gastrectomy and Open Total Gastrectomy

What Symptom Improvement Can Be Expected After Operation for Primary Hyperparathyroidism?